The Pathology and Imaging of Coronavirus Pneumonia / edited by Hongjun Li [and three others].

Format:

Book

Contributor:

Li, Hongjun, editor.

Language:

English

Subjects (All):

COVID-19 (Disease).

Viral pneumonia.

Physical Description:

1 online resource (334 pages)

Edition:

First edition.

Place of Publication:

London, England : Academic Press, [2025]

Summary:

The Pathology and Imaging of Coronavirus Pneumonia is a comprehensive study of the coronavirus family-related pulmonary diseases, specifically targeting the three subtypes of coronaviruses that have been confirmed to infect humans: SARS, MERS, and COVID-19.

Contents:

Front Cover

THE PATHOLOGY AND IMAGING OF CORONAVIRUS PNEUMONIA

Copyright

Contents

Contributors

About the editors

Preface

Brief introduction

List of editorial board members

1 - Overview

1.1 The discovery and types of coronaviruses

1.2 Types of human coronavirus

1.3 The hazards of coronaviruses

Bibliography

2 - Etiology

2.1 Morphological structure and physicochemical properties of coronaviruses

2.1.1 Morphological structure

2.1.2 Physicochemical properties

2.2 Isolation and culture of coronavirus

2.2.1 Collection of specimens

2.2.1.1 Collection objects

2.2.1.2 Requirements for specimen collection

2.2.1.3 Type of specimen collection

2.2.1.4 Method of specimen collection

2.2.1.5 Specimen packaging

2.2.1.6 Specimen storage

2.2.1.7 Specimen submission

2.2.2 Virus isolation and culture

2.3 Genetic structure and replication of coronavirus

2.3.1 Gene structure

2.3.2 Virus replication process

2.3.2.1 Adsorption and penetration

2.3.2.2 Uncoating and replication

2.3.2.3 Assembly and release

3 - Epidemiology

3.1 Epidemic profile

3.1.1 Prevalence of severe acute respiratory syndrome (SARS)

3.1.2 Prevalence of middle east respiratory syndrome (MERS)

3.1.3 Prevalence of coronavirus disease 2019 (COVID-19)

3.2 Source of infection

3.2.1 Infection source of SARS

3.2.2 Infection source of MERS

3.2.3 Infection source of COVID-19

3.3 Route of transmission

3.3.1 Transmission route of SARS

3.3.2 Transmission route of MERS

3.3.3 Transmission route of COVID-19

3.4 Susceptible population

3.4.1 Susceptible population of SARS

3.4.2 Susceptible population of MERS

3.4.3 Susceptible population of COVID-19

3.5 Epidemiologic characteristics.

3.5.1 Epidemiologic characteristics of SARS

3.5.2 Epidemiologic characteristics of MERS

3.5.3 Epidemiologic characteristics of COVID-19

4 - Pathogenesis and pathophysiology

4.1 Section 1 Pathogenesis

4.1.1 Receptor binding theory

4.1.2 Immune damage theory

4.1.3 Cytokine storm theory

4.1.4 Direct damage theory

4.1.5 Endothelial injury theory

4.2 Section 2 Pathophysiology

4.2.1 Fever

4.2.2 Hypoxia

4.2.3 ARDS

4.2.4 Shock

4.2.5 Acid-base disturbance

5 - Pathological manifestations

5.1 Pathological manifestations of SARS

5.1.1 Pulmonary lesions

5.1.2 Damage to immune organs

5.1.3 Vasculopathy

5.1.4 Systemic toxic changes

5.2 Pathological manifestations of MERS

5.3 Pathological manifestations of COVID-19

5.3.1 Pulmonary lesions

5.3.1.1 Lesions in exudative stage

5.3.1.2 Lesions of proliferative stage

5.3.2 Extrapulmonary lesions

5.3.3 Underlying lesions

5.3.4 Cause of death

5.3.5 Pathological diagnosis and differential diagnosis

6 - Clinical manifestations

6.1 Clinical manifestations of SARS

6.2 Clinical manifestations of MERS

6.3 Clinical manifestations of COVID-19

6.3.1 Main manifestations and course of disease

6.3.2 Clinical classification and clinical characteristics

6.3.3 Clinical manifestations of COVID-19 in children

6.3.4 Complications

7 - Laboratory test and other tests

7.1 Blood routine test

7.2 Blood biochemistry test

7.3 Etiological examination

7.4 Serum immunological examination

7.5 Molecular biological examination

7.5.1 Real-time fluorescence RT-PCR detection of novel coronavirus nucleic acid

7.5.2 Virus gene sequencing

7.6 Blood gas analysis

7.7 Pulmonary function examination

8 - Imaging examination technologies.

8.1 Coronavirus pneumonia imaging scanning scheme as well as CT and DR quality control in operating procedures

8.1.1 Fever clinic or independent DR examination scheme

8.1.1.1 Examination precautions

8.1.1.2 Imaging examination scheme

8.1.2 Bedside photographic examination scheme

8.1.2.1 Examination precautions

8.1.2.2 Imaging examination scheme

8.1.3 CT examination scheme

8.1.3.1 Examination precautions

8.1.3.2 Common examination scheme

8.1.3.2.1 Preparation before examination

8.1.3.2.2 Scanning process

8.1.3.2.3 CT scanning parameters (Table 8.1)

8.1.3.2.4 CT image reconstruction

8.1.3.2.5 Disinfection after examination

8.1.3.2.6 CT image postprocessing technology

8.1.4 Imaging examination scheme for special population

8.1.4.1 Imaging examination for children

8.1.4.2 Chest CT examination for pregnant women

8.1.5 Quality control in CT and DR operating procedures

8.1.5.1 Strictly follow correct operating procedures

8.1.5.2 Environment management

8.1.5.3 Equipment maintenance management

8.1.6 Other imaging examinations

8.2 Infection control and management measures for imaging equipment of primary hospitals and mobile cabin hospitals

8.2.1 Primary task of imaging department in primary hospital

8.2.2 Mobile cabin hospitals

8.2.3 Management requirements for imaging diagnosis inspection equipment

9 - Imaging manifestations of SARS

9.1 Imaging manifestations in early stage

9.1.1 Imaging manifestations

9.1.1.1 X-ray

9.1.1.2 CT

9.1.2 Case description

9.1.3 Diagnostic key points

9.2 Imaging manifestations in progressive stage

9.2.1 Imaging manifestations at progressive stage

9.2.1.1 X-ray

9.2.1.2 CT

9.2.2 Case description

9.2.3 Diagnostic key points

9.3 Imaging manifestations in convalescence stage.

9.3.1 Imaging manifestations

9.3.1.1 Dynamic evolution of SARS imaging

9.3.1.2 Pathological basis of imaging manifestations

9.3.1.3 Imaging manifestations of complications

9.3.2 Case description

9.3.3 Diagnostic key points

10 - Imaging manifestations of MERS

10.1 Overview of MERS

10.2 Imaging manifestations and diagnosis of MERS

10.2.1 Imaging manifestations of MERS

10.2.2 Key points for imaging differential of SARS, MERS and COVID-19

10.2.3 Case description

10.2.4 Diagnostic key points

11 - Imaging manifestations of COVID-19

11.1 Imaging manifestations in early stage

11.1.1 Clinical characteristics

11.1.2 Imaging manifestations

11.1.3 Case description

11.1.4 Diagnostic key points

11.2 Imaging manifestations in progressive stage

11.2.1 Clinical characteristics

11.2.2 Imaging manifestations

11.2.3 Case description

11.2.4 Diagnostic key points

11.3 Imaging manifestations in recovery stage

11.3.1 Clinical characteristics

11.3.2 Imaging manifestations in recovery stage

11.3.3 Case description

11.3.4 Diagnostic key points

11.4 Imaging manifestations of severe and critical patients

11.4.1 Clinical characteristics

11.4.2 Imaging manifestations

11.4.3 Case description

11.4.4 Diagnostic key points

11.5 Imaging manifestations of special population

11.5.1 Infants and young children

11.5.1.1 Clinical characteristics

11.5.1.2 Imaging manifestations

11.5.1.2.1 X-ray

11.5.1.2.2 HRCT

11.5.1.3 Case description

11.5.1.4 Diagnostic key points

11.5.2 Children and adolescents

11.5.2.1 Clinical characteristics

11.5.2.2 Imaging manifestations

11.5.2.2.1 X-ray

11.5.2.2.2 HRCT

11.5.2.3 Case description

11.5.2.4 Diagnostic key points

11.5.3 Patients in midtrimester pregnancy.

11.5.3.1 Case description

11.5.3.2 Diagnostic key points

11.5.4 The elderly

11.5.4.1 Clinical characteristics

11.5.4.2 Imaging manifestations

11.5.4.2.1 X-ray manifestations

11.5.4.2.2 CT manifestations

11.5.4.3 Case description

11.5.4.4 Diagnostic key points

11.5.5 Patients with underlying diseases

11.5.5.1 Clinical characteristics

11.5.5.2 Imaging manifestations

11.5.5.2.1 X-ray

11.5.5.2.2 HRCT

11.5.5.3 Case description

11.5.5.4 Diagnostic key points

11.6 Imaging manifestation of re-positive cases of viral nucleic acid testing

11.6.1 Clinical characteristics

11.6.2 Imaging manifestations

11.6.3 Case description

11.6.4 Diagnostic key points

11.7 Imaging manifestations of asymptomatic infected persons

11.7.1 Clinical characteristics

11.7.2 Imaging manifestations of asymptomatic infected persons

11.7.3 Case description

11.7.4 Diagnostic key points

11.8 Imaging manifestations of COVID-19 complications

11.8.1 Clinical characteristics

11.8.2 Imaging manifestations of COVID-19 complications

11.8.2.1 Respiratory complications

11.8.2.2 Circulatory complications

11.8.2.3 Digestive complications

11.8.2.4 Neurological complications

11.8.3 Case description

11.8.4 Diagnostic key points

11.9 Imaging manifestations of heart disease with COVID-19

11.9.1 Clinical characteristics

11.9.2 MR manifestations of heart diseases

11.9.3 Case description

11.9.4 Diagnostic key points

11.10 Imaging manifestations of neurological lesions with COVID-19

11.10.1 Clinical characteristics

11.10.2 Imaging manifestations of neurological lesions

11.10.3 Case description

11.10.4 Diagnostic key points

11.11 Imaging manifestations of digestive system lesions with COVID-19

11.11.1 Clinical characteristics.

11.11.2 Imaging manifestations of digestive system lesions.

Notes:

Includes bibliographical references and index.

Description based on publisher supplied metadata and other sources.

Description based on print version record.

ISBN:

9780443329319

0443329311

OCLC:

1474241496